Incidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysis.
<h4>Background</h4>We conducted a systematic review and meta-analysis to clarify the incidence and risk of cardiotoxicity associated with bortezomib in cancer patients.<h4>Methods</h4>Databases from PubMed, Web of Science and abstracts presented at ASCO meeting up to July 31,...
Saved in:
| Main Authors: | Yi Xiao, Jin Yin, Jia Wei, Zhen Shang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087671&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug repurposing: Bortezomib in the treatment of PTEN‐deficient iCCA
by: Shi‐jia Dai, et al.
Published: (2024-12-01) -
Bortezomib-Induced Complete Heart Block and Myocardial Scar: The Potential Role of Cardiac Biomarkers in Monitoring Cardiotoxicity
by: Sachin Diwadkar, et al.
Published: (2016-01-01) -
Cardiotoxicity in cancer immunotherapy: a systematic review and global meta-analysis
by: Fanlin Zhou, et al.
Published: (2025-07-01) -
Incidence, characteristics, and treatments of peripheral neuropathy in multiple myeloma patients receiving bortezomib (velcade)
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Bortezomib
by: Rajappa Senthil
Published: (2010-12-01)